Leukemia

Autologous T Lymphocytes Specifically Recognize Leukemic B Cells

Published in Vaccine Weekly, February 14th, 2001

- by Michelle Marble, staff medical writer -- According to a study from Sweden, the spontaneous immunity found in some chronic lymphocytic leukemia (CLL) patients could be harnessed in a vaccine.

"This study analyzed a naturally-occurring specific cellular immunity against tumor cells in chronic lymphocytic leukemia (CLL) patients," stated M.R. Rezvany and colleagues, Karolinska Hospital. "Five out of eight patients had blood T lymphocytes able to recognize spontaneously and specifically the autologous tumor B cells (proliferation assay)."

Rezvany et al. published the results of their study in the British Journal of Hematology ("Autologous T...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2001-02-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry